RSS   Newsletter   Contact   Advertise with us
Post Online Media

Allergy Therapeutics appoints Nick Wykeman as finance director

Nick WykemanAllergy Therapeutics, a specialty pharmaceutical company, announced the appointment of Nick Wykeman to the board as finance director.

Mr. Wykeman was most recently at Skyepharma PLC until August 2015 where he was the Group Financial Controller for six years.

Prior to that, he had also worked at Quest International (a part of ICI PLC) as the Group Financial Controller (Special Projects), following six years at Deloitte & Touche.

Mr. Wykeman has a BSc (Hons) in Economics and is a qualified accountant, being a member of the Institute of Chartered Accountants of England and Wales.


 LATEST MOVES FROM United Kingdom 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy